Prelude Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
|
|||||
|
2025
Q1 | $1.14M | Buy |
|
|||||
|
2024
Q4 | $545K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $236K | Sell |
|
|||||
|
2022
Q2 | $275K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $8K | Sell |
|
|||||
|
2020
Q2 | $83K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $6K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $88K | Buy |
|
|||||
|
2018
Q4 | $21K | Sell |
|
|||||
|
2018
Q3 | $834K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $18K | Sell |
|
|||||
|
2017
Q3 | $1.64M | Buy |
|
|||||
|
2017
Q2 | $232K | Sell |
|
|||||
|
2017
Q1 | $201K | Buy |
|
|||||
|
2016
Q4 | $115K | Buy |
|
|||||
|
2016
Q3 | $14K | Sell |
|
|||||
|
2016
Q2 | $50K | Sell |
|
|||||
|
2016
Q1 | $126K | Sell |
|
|||||
|
2015
Q4 | $624K | Buy |
|
|||||
|
2015
Q3 | $292K | Buy |
|
|||||
|
2015
Q2 | $409K | Sell |
|
|||||
|
2015
Q1 | $485K | Buy |
|
|||||
|
2014
Q4 | $468K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $87K | Sell |
|
|||||
|
2013
Q4 | $327K | Buy |
|
|||||
|
2013
Q3 | $268K | Sell |
|
|||||
|
2013
Q2 | $403K | Buy |
|